How Australia Is Reshaping Clinical Trials | Daniel Evans

Dr. David Bearss sits down with Daniel Evans of Southern Star Research to explore how Australia is becoming a global leader in Phase 1 clinical trials. They discuss how the country’s streamlined regulatory environment and government incentives are helping biotech companies move faster and more efficiently. Australia’s bold approach is challenging outdated global standards. If you’re in biotech, pharma, or curious about the future of clinical research, this episode offers a glimpse into a more agile, innovative path forward.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠